Investors Heavily Search Alphabet Inc. (GOOG): Here is What You Need to Know — Positive
GOOG GOOGL Zacks Investment Research — October 08, 2025Alphabet (GOOG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
General Motors Company (GM) is Attracting Investor Attention: Here is What You Should Know — Positive
GM Zacks Investment Research — October 08, 2025General Motors (GM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know — Positive
OGN Zacks Investment Research — October 08, 2025Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Robinhood Markets, Inc. (HOOD) Is a Trending Stock: Facts to Know Before Betting on It — Positive
HOOD Zacks Investment Research — October 08, 2025Robinhood Markets (HOOD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Trending Stock Gray Media Inc. (GTN) a Buy Now? — Positive
GTN Zacks Investment Research — October 08, 2025Gray Media (GTN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here is What to Know Beyond Why Verizon Communications Inc. (VZ) is a Trending Stock — Positive
VZ Zacks Investment Research — October 08, 2025Verizon (VZ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Most-Watched Stock American Eagle Outfitters, Inc. (AEO) Worth Betting on Now? — Positive
AEO Zacks Investment Research — October 08, 2025Zacks.com users have recently been watching American Eagle (AEO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Nextracker Inc. (NXT) Is a Trending Stock: Facts to Know Before Betting on It — Positive
NXT Zacks Investment Research — October 08, 2025Recently, Zacks.com users have been paying close attention to Nextracker (NXT). This makes it worthwhile to examine what the stock has in store.
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know — Positive
VRTX Zacks Investment Research — October 08, 2025Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Powell Industries, Inc. (POWL) Is a Trending Stock: Facts to Know Before Betting on It — Positive
POWL Zacks Investment Research — October 08, 2025Powell Industries (POWL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Western Digital Corporation (WDC) Is a Trending Stock: Facts to Know Before Betting on It — Positive
WDC Zacks Investment Research — October 08, 2025Western Digital (WDC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Trending Stock Deere & Company (DE) a Buy Now? — Positive
DE Zacks Investment Research — October 08, 2025Zacks.com users have recently been watching Deere (DE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investors Heavily Search CLEAR Secure, Inc. (YOU): Here is What You Need to Know — Positive
YOU Zacks Investment Research — October 08, 2025Clear Secure (YOU) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Chevron Corporation (CVX) Is a Trending Stock: Facts to Know Before Betting on It — Positive
CVX Zacks Investment Research — October 08, 2025Chevron (CVX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here is What to Know Beyond Why PulteGroup, Inc. (PHM) is a Trending Stock — Positive
PHM Zacks Investment Research — October 08, 2025Zacks.com users have recently been watching PulteGroup (PHM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know — Positive
NVAX Zacks Investment Research — October 08, 2025Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Here is What to Know Beyond Why Strategy Inc (MSTR) is a Trending Stock — Positive
MSTR Zacks Investment Research — October 08, 2025Zacks.com users have recently been watching Strategy (MSTR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Visa Inc. (V) Is a Trending Stock: Facts to Know Before Betting on It — Positive
V Zacks Investment Research — October 08, 2025Visa (V) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investors Heavily Search Toll Brothers Inc. (TOL): Here is What You Need to Know — Positive
TOL Zacks Investment Research — October 08, 2025Toll Brothers (TOL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Lisata Therapeutics inks global product license deal with Catalent — Positive
CTLT LSTA Proactive Investors — October 08, 2025Lisata Therapeutics Inc (NASDAQ:LSTA) announced that it has entered into a global product license agreement with Catalent Inc, which would allow Catalent to incorporate Lisata's certepetide into antibody-drug conjugates (ADCs) developed using Catalent's SMARTag technology platform. The clinical-stage pharmaceutical company said Certepetide, a proprietary, internalizing RGD (arginyl-glycyl-aspartic acid), or “iRGD” cyclic peptide, is being tested by Lisata as a cancer therapeutic to be used in combination with other anti-cancer agents to enhance tumor targeting and penetration and improve treatment outcomes.
